Atlas Trials

Continuing Cetuximab Plus Chemotherapy After First Progression in Wild-type KRAS, NRAS and BRAF V600E Metastatic Colorectal Cancer

Clinical trial NCT04718038 · COMPLETED

Trial details

NCT number
NCT04718038
Sponsor
Henan Cancer Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Wild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer
Start date
2016-07-01
Primary completion
2018-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.